Patents
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
02/2004
02/05/2004US20040023927 Bicyclic imidazo-5-yl-amine derivatives
02/04/2004EP1385854A1 Thiazolopyrimidines and their use as modulators of chemokine receptor activity
02/04/2004EP1268488A4 A process for preparing cephalosporin derivatives using new thiazole compound
02/04/2004CN1473162A Bicyclic triazolone derivatives and herbicides containing the same
02/04/2004CN1473161A Pyrazole compounds as protein kinase inhibitors
02/04/2004CN1137125C Fused 1,2,4-thiadiazine derivatives, their preparation and use
02/04/2004CN1137100C Tricyclic compounds capable of inhibiting tyrosine kinases of epidermal growth factor receptor family
02/03/2004US6685617 4-(((-1-carboxy-2-(4-((2,6-dichlorobenzoyl)amine)phenyl)ethyl) amino)carbonyl)-3-oxo-3-thiazolidinebutanoic acid, used as antagonists for cellular adhesion molecules, and administered as antiinflammatory agents
01/2004
01/29/2004US20040019079 Beta3-Adrenoreceptor agonists, agonist compositions and methods of using
01/29/2004US20040019061 1-H-3-arylpirrolidine-2,4-dione derivatives
01/29/2004US20040019050 Selective NPY (Y5) antagonists (triazines)
01/29/2004US20040019019 Administering a bicyclic or tricyclic amidino derivative compounds for the treatment of diseases mediated by nitric oxide synthase
01/29/2004US20040018963 O-derivatized nocathiacin derivatives
01/28/2004EP1384723A1 4-Hydroxy-2H-thieno[2,3-e]-1,2-thiazin-3-carboxamide-1,1-dioxides, process for their preparation and pharmaceutical compositions containing them
01/28/2004EP1383773A2 Novel insecticidal azoles
01/28/2004EP1383771A1 9-deazaguanine derivatives as inhibitors of gsk-3
01/28/2004EP1383741A2 Process for the preparation of benazepril
01/28/2004EP1383733A2 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
01/28/2004EP1299378A4 Tetrahydropyridino or piperidino heterocyclic derivatives
01/28/2004EP1218382B1 Bicyclic imidazo-3-yl-amine derivatives
01/28/2004CN1136193C Imide derivatives ar Salts thereof
01/27/2004US6682782 Organic compound having an acetylene group, vacuum deposition polymerization thereof, deposited polymerized thin film, and electroluminescence device containing same
01/22/2004WO2003059356A3 Novel anti-infectives
01/22/2004US20040014783 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders
01/22/2004US20040014756 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
01/22/2004US20040014750 Therapy, prevention atherosclerosis; cardiovascular disorders; anticholesterol agents; bactericides; prevention infections
01/22/2004US20040014749 Sulfhydryl rifamycins and uses thereof
01/22/2004US20040014743 Mbreast and prostate anticancer agents; viricides; alopecia
01/21/2004EP1382607A2 Prenyl transferase inhibitors
01/21/2004CN1469875A Pyrazole compounds useful as protein kinase inhibitors
01/21/2004CN1469874A Pyrazole compounds useful as protein kinase inhibitors
01/15/2004WO2004005472A2 Inhibitors of ftsz and uses thereof
01/15/2004WO2004005299A1 Polymorphic forms of a 4h-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivative
01/15/2004WO2004005278A1 Bisarylsulfonamide compounds and their use in cancer therapy
01/15/2004WO2004004720A1 3-`(hetero) arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors
01/15/2004WO2004004646A2 O-derivatized nocathiacin derivatives
01/15/2004US20040010142 Potassium channel moderators; antidiabetic agents
01/15/2004US20040009984 Increasing levels of endogenous growth hormone, especially treating osterporosis, aging frailty or congestive heart failure
01/15/2004US20040009967 May contain further anticancer or immunosuppressive agents
01/15/2004DE10229370A1 2,1,3-Benzothiadiazole 2,1,3-benzothiadiazoles
01/15/2004CA2491074A1 O-derivatized nocathiacin derivatives
01/15/2004CA2488816A1 Bisarylsulfonamide compounds and their use in cancer therapy
01/14/2004EP1380587A2 Oxazolo, thiazolo and selenazolo (4,5-c)-quinoline-4-amines and analogs thereof
01/14/2004EP1379243A1 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors
01/14/2004EP1222195B1 Novel thiazolo(4,5-d)pyrimidine compounds
01/14/2004CN1468241A Heterocyclic compounds as ligands of the gabaa receptor
01/14/2004CN1468232A Heterocyclic sodium/proton exchange inhibitors and method
01/14/2004CN1468217A Aliphatic nitrogenous five-membered ring compounds
01/14/2004CN1468216A Nitrogenous five-membered ring compounds
01/14/2004CN1468211A Nitroso diphenylamine derivatives
01/14/2004CN1134421C Antifungal and its preparation method and intermediate
01/13/2004US6677334 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
01/08/2004WO2004002992A1 Compounds
01/08/2004WO2004002970A1 2,1,3-benzothiadiazoles for use as electronic active components
01/08/2004WO2004002490A2 Piperidine compounds as antibacterials
01/08/2004WO2002059124A3 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
01/08/2004US20040006080 Chemical compounds
01/08/2004US20040006063 Dipeptide derivatives
01/07/2004EP1377971A1 Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer
01/07/2004EP1377590A1 Thiazolopyrimidine derivatives and use thereof as antagonists of the cx3 cr1 receptor
01/06/2004CA2247063C Treatment of macular edema
01/02/2004EP1375489A1 Medicinal composition containing 1,3-thiazine derivative
01/02/2004EP1375486A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
01/01/2004US20040002527 Indolylalkylidenehydrazine-carboximidamide derivatives as 5-hydroxytryptamine-6 ligands
01/01/2004US20040002495 Lactam glycogen phosphorylase inhibitors and method of use
01/01/2004US20040002488 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
12/2003
12/31/2003WO2004000849A2 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity
12/31/2003CA2445515A1 Transcription factor modulating compounds and methods of use thereof
12/30/2003US6670386 For therapy of nuclear hormone receptor-associated conditions, such as age related diseases, for example sarcopenia
12/25/2003US20030236265 Bactericides; autoimmune disease; antiinflammatory agents; administering a synergistic mixture of rifamycin and another antibiotic
12/25/2003US20030236245 Helix mimetics and composition and methods related thereto
12/25/2003US20030236229 For stimulating the immune system, treating proliferative disorders, or microbial infections
12/24/2003WO2003106430A1 Benzimidazole inhibitors of poly(adp-ribosyl) polymerase
12/24/2003WO2003105881A1 Use of amide derivative of ge 2270 factor a3 for the treatment of acne
12/24/2003WO2003051299A3 Sulfhydryl rifamycins and uses thereof
12/24/2003CN1131870C 新的吡咯磺酰胺化合物 The new pyrrole sulfonamide compound
12/23/2003US6667306 Platelet ADP receptor inhibitors
12/23/2003US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders
12/23/2003CA2233178C (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
12/18/2003WO2003066630A3 Quinolinone derivatives for treating cell proliferation related disorders
12/18/2003WO2003064431A3 Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
12/18/2003WO2003015773A3 2-amino-4,5-trisubstituted thiazolyl derivatives and their use against autoimmune diseases
12/18/2003US20030232828 1-(aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands
12/18/2003US20030232821 Oxadiazine derivatives
12/18/2003US20030232808 Sulfonyl derivatives
12/18/2003US20030232794 Fused nitrogen heterocycle derivatives useful to inhibit cancer or sensitize cancer cells to chemotherapeutic agents, radiation or other anti-cancer treatments
12/18/2003US20030232215 Organic Red Electro-Luminescent Device and Dopant
12/17/2003EP1370260A2 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
12/17/2003EP1319010B1 Tricyclic mercaptomethyl-substituted 2,3-dihydro-quinazolin-5-ones and 2,3-dihydro-benzo-[1,2,4]-thiadiazin-5,5-dioxides as matrix metalloproteinase (mmp) inhibitors
12/17/2003EP1218380B1 Bicyclic imidazo-3-yl-amine derivatives which are substituted on the sixth ring
12/16/2003US6664251 Benzothiazine derivative
12/16/2003US6664247 Pyrazole compounds useful as protein kinase inhibitors
12/11/2003WO2003101994A1 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
12/11/2003WO2003101985A1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders
12/11/2003WO2003101962A1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands
12/11/2003WO2003101445A1 Intravenous rifalazil formulation and methods of use thereof
12/11/2003WO2003051300A3 Metal complexes and formulations of rifamycin analogues and uses therof
12/11/2003US20030229095 Sexual disorders
12/11/2003US20030229089 Cyclic compounds
12/11/2003US20030229080 Cardiovascular disorders; sexual disorders
1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 152